{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:43:37Z","timestamp":1777509817129,"version":"3.51.4"},"reference-count":49,"publisher":"SAGE Publications","issue":"5","license":[{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cell Transplant"],"published-print":{"date-parts":[[2005,5]]},"abstract":"<jats:p>Around 80\u201395% of the immature dopaminergic neurons die when embryonic ventral mesencephalic tissue is transplanted. Cell death occurs both during the preparation of donor tissue and after graft implantation, but the effect of combining successful neuroprotective treatments before and after transplantation has not been extensively investigated. We therefore treated embryonic rat mesencephalic tissue with a combination of the lipid peroxidation inhibitor tirilazad mesylate (3 \u03bcM) and the caspase inhibitor Ac.YVAD.cmk (500 \u03bcM) and transplanted the tissue into hemiparkinsonian rats kept hypothermic (32\u201333\u00b0C) or normothermic (37\u00b0C) during, and 90 min following, graft surgery. Suspension cell number did not differ between untreated or tirilazad\/YVAD-treated preparations prior to transplantation. When graft survival was evaluated 6 weeks after implantation, both tirilazad\/YVAD pretreatment and mild hypothermia increased the survival of transplanted dopaminergic neurons. Approximately 50\u201357% of the embryonic dopaminergic neurons survived the dissociation and grafting procedure in rats rendered hypothermic, but there was no significant additive effect on graft survival with a combined treatment. All groups of rats exhibited behavioral recovery in the amphetamine-induced rotation test. There was a significantly enhanced functional capacity of grafts placed in hypothermic as compared to normothermic rats. However, tirilazad\/YVAD pretreated implants did not afford greater behavioral improvement than control-treated grafts. Our results suggest that neuroprotective treatments administered prior to and immediately after neural graft implantation may under certain conditions rescue, at least in part, the same subset of dopaminergic neurons. The study also emphasizes the importance of the immediate time after grafting for transplant survival, with relevance both for primary mesencephalic implants and stem cell grafts.<\/jats:p>","DOI":"10.3727\/000000005783983089","type":"journal-article","created":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T20:30:47Z","timestamp":1207081847000},"page":"301-309","source":"Crossref","is-referenced-by-count":16,"title":["Combining Neuroprotective Treatment of Embryonic Nigral Donor Tissue with Mild Hypothermia of the Graft Recipient"],"prefix":"10.1177","volume":"14","author":[{"given":"Jenny","family":"Karlsson","sequence":"first","affiliation":[{"name":"Neuronal Survival Unit, Wallenberg Neuroscience Center, Department of Experimental Medical Science, Lund University, SE-221 84 Lund, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c5Sa","family":"Peters\u00e9n","sequence":"additional","affiliation":[{"name":"Neuronal Survival Unit, Wallenberg Neuroscience Center, Department of Experimental Medical Science, Lund University, SE-221 84 Lund, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gunilla","family":"Gid\u00f6","sequence":"additional","affiliation":[{"name":"Laboratory for Experimental Brain Research, Wallenberg Neuroscience Center, Lund University Hospital, SE-221 84 Lund, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadeusz","family":"Wieloch","sequence":"additional","affiliation":[{"name":"Laboratory for Experimental Brain Research, Wallenberg Neuroscience Center, Lund University Hospital, SE-221 84 Lund, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrik","family":"Brundin","sequence":"additional","affiliation":[{"name":"Neuronal Survival Unit, Wallenberg Neuroscience Center, Department of Experimental Medical Science, Lund University, SE-221 84 Lund, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2005,5]]},"reference":[{"key":"e_1_2_1_1_2_2","doi-asserted-by":"publisher","DOI":"10.3727\/000000003108746795"},{"key":"e_1_2_1_1_3_2","doi-asserted-by":"publisher","DOI":"10.1006\/exnr.1996.0141"},{"key":"e_1_2_1_1_4_2","doi-asserted-by":"publisher","DOI":"10.1006\/exnr.1997.6655"},{"key":"e_1_2_1_1_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)60979-2"},{"key":"e_1_2_1_1_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(85)91550-1"},{"key":"e_1_2_1_1_7_2","doi-asserted-by":"publisher","DOI":"10.1177\/096368970000900205"},{"key":"e_1_2_1_1_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/123.7.1380"},{"key":"e_1_2_1_1_9_2","first-page":"171","article-title":"Postischemic hypothermia.","volume":"14","author":"Colbourne F.","year":"1997","unstructured":"ColbourneF. SutherlandG. CorbettD. Postischemic hypothermia. A critical appraisal with implications for clinical treatment. Mol. Neurobiol. 14: 171-201; 1997.","journal-title":"A critical appraisal with implications for clinical treatment. Mol. Neurobiol."},{"key":"e_1_2_1_1_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4522(00)00312-2"},{"key":"e_1_2_1_1_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9568.1990.tb00419.x"},{"key":"e_1_2_1_1_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4522(00)00299-2"},{"key":"e_1_2_1_1_13_2","first-page":"29","article-title":"Intracerebral grafting of neuronal cell suspensions.","volume":"522","author":"Dunnett S. B.","year":"1983","unstructured":"DunnettS. B. Bj\u00f6rklundA. SchmidtR. H. SteneviU. IversenS. D. Intracerebral grafting of neuronal cell suspensions. IV. Behavioural recovery in rats with unilateral 6-OHDA lesions following implantation of nigral cell suspensions in different forebrain sites. Acta Physiol. Scand. Suppl. 522: 29-37; 1983.","journal-title":"IV. Behavioural recovery in rats with unilateral 6-OHDA lesions following implantation of nigral cell suspensions in different forebrain sites. Acta Physiol. Scand. Suppl."},{"key":"e_1_2_1_1_14_2","doi-asserted-by":"publisher","DOI":"10.1006\/exnr.1999.7198"},{"key":"e_1_2_1_1_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4522(02)00480-3"},{"key":"e_1_2_1_1_16_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.2003.01931.x"},{"key":"e_1_2_1_1_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00241123"},{"key":"e_1_2_1_1_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0955-0674(00)00251-9"},{"key":"e_1_2_1_1_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnen\/60.8.741"},{"key":"e_1_2_1_1_20_2","first-page":"161","volume-title":"Neuroprotection in CNS diseases.","author":"Hall E. D.","year":"1997","unstructured":"HallE. D. Lipid antioxidant neuroprotectants for acute and chronic neurodegenerative disorders. In: B\u00e4rP. R. BealM. F., eds. Neuroprotection in CNS diseases. New York: Marcel Dekker Inc.; 1997: 161-181."},{"key":"e_1_2_1_1_21_2","doi-asserted-by":"publisher","DOI":"10.1006\/exnr.2000.7406"},{"key":"e_1_2_1_1_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(95)01427-6"},{"key":"e_1_2_1_1_23_2","doi-asserted-by":"publisher","DOI":"10.1006\/exnr.2001.7709"},{"key":"e_1_2_1_1_24_2","doi-asserted-by":"publisher","DOI":"10.1006\/exnr.2001.7749"},{"key":"e_1_2_1_1_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(98)00702-1"},{"key":"e_1_2_1_1_26_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001756-200006050-00014"},{"key":"e_1_2_1_1_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(02)03601-6"},{"key":"e_1_2_1_1_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-0102(98)00076-5"},{"key":"e_1_2_1_1_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870130303"},{"key":"e_1_2_1_1_30_2","doi-asserted-by":"publisher","DOI":"10.1006\/exnr.1994.1144"},{"key":"e_1_2_1_1_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9568.1990.tb00400.x"},{"key":"e_1_2_1_1_32_2","doi-asserted-by":"publisher","DOI":"10.1097\/00075198-200204000-00004"},{"key":"e_1_2_1_1_33_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.289.22.2992"},{"key":"e_1_2_1_1_34_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.26.12408"},{"key":"e_1_2_1_1_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(94)91532-6"},{"key":"e_1_2_1_1_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-2236(96)80038-5"},{"key":"e_1_2_1_1_37_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.15-05-03863.1995"},{"key":"e_1_2_1_1_38_2","doi-asserted-by":"publisher","DOI":"10.1006\/exnr.1997.6594"},{"key":"e_1_2_1_1_39_2","first-page":"979","article-title":"Glial cell line-derived neurotrophic factor increases survival, growth and function of intrastriatal fetal nigral dopaminergic grafts.","volume":"75","author":"Rosenblad C.","year":"1996","unstructured":"RosenbladC. Martinez-SerranoA. Bj\u00f6rklundA. Glial cell line-derived neurotrophic factor increases survival, growth and function of intrastriatal fetal nigral dopaminergic grafts. Neuroscience 75: 979-985; 1996.","journal-title":"Neuroscience"},{"key":"e_1_2_1_1_40_2","doi-asserted-by":"publisher","DOI":"10.3233\/RNN-1991-2302"},{"key":"e_1_2_1_1_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(93)90560-A"},{"key":"e_1_2_1_1_42_2","first-page":"131","volume-title":"Innovative models of CNS disease: From molecule to therapy.","author":"Schallert T.","year":"1999","unstructured":"SchallertT. TillersonJ. L. Intervention strategies for degeneration of dopamine neurons in Parkinsonism: Optimising behavioral assessment of outcome. In: Innovative models of CNS disease: From molecule to therapy. Clifton, NJ: Humana; 1999: 131-151."},{"key":"e_1_2_1_1_43_2","doi-asserted-by":"publisher","DOI":"10.1038\/4785"},{"key":"e_1_2_1_1_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(98)01640-8"},{"key":"e_1_2_1_1_45_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001756-199904260-00020"},{"key":"e_1_2_1_1_46_2","doi-asserted-by":"publisher","DOI":"10.1006\/exnr.2000.7476"},{"key":"e_1_2_1_1_47_2","doi-asserted-by":"publisher","DOI":"10.1006\/exnr.2001.7644"},{"key":"e_1_2_1_1_48_2","doi-asserted-by":"publisher","DOI":"10.2741\/1096"},{"key":"e_1_2_1_1_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(97)01408-X"},{"key":"e_1_2_1_1_50_2","doi-asserted-by":"publisher","DOI":"10.3727\/000000002783985396"}],"container-title":["Cell Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.3727\/000000005783983089","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.3727\/000000005783983089","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T15:35:44Z","timestamp":1777390544000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.3727\/000000005783983089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["10.3727\/000000005783983089"],"URL":"https:\/\/doi.org\/10.3727\/000000005783983089","relation":{},"ISSN":["0963-6897","1555-3892"],"issn-type":[{"value":"0963-6897","type":"print"},{"value":"1555-3892","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,5]]}}}